17α-Hydroxylase Deficiency Accompanied by Adrenal Myelolipoma

Internal Medicine

Volumn 40, Issue 9, 2001, Pages 920-923

  Nagai, Takashi ^a   Imamura, Makoto ^a   Honma, Manabu ^a   Murakami, Masami ^b   Mori, Masatomo ^a  

^a Public Tomioka General Hospital   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Amenorrhea; Hypertension; Hypokalemia; Inciden taloma

Indexed keywords

HORMONE; HYDROXYPROGESTERONE;

ADRENAL TUMOR; ARTICLE; BLOOD; CASE REPORT; CONGENITAL ADRENAL HYPERPLASIA; ENZYMOLOGY; FEMALE; HUMAN; MIDDLE AGED; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL GLAND NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; HORMONES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELOLIPOMA; TREATMENT OUTCOME;

EID: 0035462279     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.920     Document Type: Article

References (14)

1. Yanase T., Simpson ER, Waterman MR. 17α-hydroxylase/17, 20-lase deficiency: From clinical investigation to molecular definition. Endocr Rev 12: 91–108, 1991.
2. Soundy TJ, Black JL, Peterson GC, Zimmerman D. Psychosis in a male psuedohermaphrodite with 17-hydroxylase deficiency. Psychosomatics 33: 452–454, 1992.
3. 106→proline causes 17α-hydroxylase deficiency. J Biol Chem 266: 15992–15998, 1991.
4. Suzuki Y., Nagashima T., Nomura Y., Onigata K., Nagashima K., Morikawa A. A new commpound heterozygous mutation (W17X, 436+5G→T) in the cytochrome P450cl7 gene causes 17α-hydroxylase/17, 20-lase deficiency. J Clin Endocrinol Metab 83: 199–202, 1998.
5. Goldsmith O., Solomon DH, Horton R. Hypogonadism and mineralcor-ticoid excess. The 17a-hydroxylase deficiency syndrome. N Engl J Med 277: 673–677, 1967.
6. Biglieri EG, Shambelan M., Slaton PE Jr. Effects of adrenocorticotropin on deoxycorticosterone, corticosterone and aldosterone excretion. J Clin Endocrinol Metab 29: 1090–1101, 1969.
7. Han M., Burnett AL, Fishman EK, Marshall FF. The natural history and treatment of adrenal myelolipoma. J Urol 157: 1213–1216, 1997.
8. Kenney PJ, Wagner BJ, Rao P., Heffess CS. Myelolipoma: CT and pathologic features. Radiology 208: 87–95, 1998.
9. Bird IM, Pasquarette MM, Rainey WE, Mason JI. Differential contol of 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells. J Clin Endocrinol Metab 81: 2171–2178, 1996.
10. Suzuki T., Sasano H., Sawai T., Mason JI, Nagura H. Immunohistochemis-try and in-situ hybridization of P-45017 alpha (17 alpha-hydroxylase/17, 20-lyase). J Histochem Cytochem 40: 903–908, 1992.
11. Wei JQ, Wei JL, Lucarelli C., et al. Serum steroid hormonal profiles by reversed-phase liquid chromatography in patients with 17-hydroxylase deficiency and in an affected family. Clin Chem 38: 76–82, 1992.
12. Ravichandran R., Lafferty F., McGinniss MJ, Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life; report of two patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 81: 1776–1779, 1996.
13. Jaresch S., Kornely E., Kley Hans-Kuno, Schlaghecke R. Adrenal inciden-taloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 74: 685–689, 1992.
14. Murakami C., Ishibashi M., Kondo M., et al. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Intern Med 31: 803–806, 1992.